To assess our model’s dependence on the most prevalent CH-associated genes and its ability to generalize to less common CH variants, we evaluated its performance on an external validation set where all variants in the most prevalent genes in clonal hematopoietic cells (DNMT3A, TET2, and ASXL1)27 were removed. This evidence concerns the gene ASXL1 and cyclic hematopoiesis.